Ignite Creation Date:
2024-05-06 @ 9:40 AM
Last Modification Date:
2024-10-26 @ 12:18 PM
Study NCT ID:
NCT03046862
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-04-19
First Post:
2017-02-06
Brief Title:
DurvalumabMEDI4736Tremelimumab in Combination With GemcitabineCisplatin in Chemotherapy-naïve Biliary Tract Cancer
Sponsor:
Seoul National University Hospital
Organization:
Seoul National University Hospital
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-02-25
Start Date Type:
ACTUAL
Primary Completion Date:
2020-05-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2017-02-06
First Submit QC Date:
February 6 2017
Study First Post Date:
2017-02-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-17
Last Update Post Date:
2024-04-19
Last Update Post Date Type:
ACTUAL